OX40 Rezeptor bindende Agenzien
Patent europeic · EP1492813 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP1492813
- Numer da la dumonda
- EP03730172
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 02-04-2003
- Publitgà
- 05-01-2005
- Concedì
- 09-05-2012
- Stritgà
- 30-04-2013
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- C07K 14/52 (2006.01)C07K 14/705 (2006.01)C12N 15/28 (2006.01)C12N 5/10 (2006.01)C12N 15/63 (2006.01)G01N 33/53 (2006.01)A61K 38/00 (2006.01)A61P 31/00 (2006.01)A61P 35/00 (2006.01)A61P 37/00 (2006.01)
- Prioritad
- EP 02100334 03.04.2002
- Dumonda PCT
- PCT/EP2003/050089 02.04.2003
- Publicaziun PCT
- WO2003/082919 09.10.2003
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 20-11-2013
Stritgà, taxa betg pajada
Published in Swissreg on 20.11.2013
- 22-06-2012
Represchentant inscrit
- Representative
- Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva
Published in Swissreg on 22.06.2012
- 09-05-2012
Concedì
Published in Swissreg on 09.05.2012
Partidas
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.